Vancomycin in Total Knee Arthroplasty (TKA)
This study is looking at different ways to give vancomycin, an antibiotic, to prevent infections after total knee replacement surgery (TKA). Researchers want to see if injecting vancomycin directly into the joint (intraarticular) works as well as injecting it into the bone (intraosseous). The goal is to find a method that is just as effective but might involve fewer wounds, less time, and lower costs. You might be able to join if you are over 18, having your first knee replacement at UC San Diego Health, and don't have certain health conditions like a high BMI, uncontrolled diabetes, or allergies to the study medications. The main thing they will measure is how much vancomycin is found in your bone, joint tissue, fat, and blood during surgery. The study plans to enroll 30 participants, and its current status is unclear.
- Study design
- This interventional study plans to enroll 30 participants. It is comparing two ways of giving vancomycin.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary measurements are taken during surgery (intraoperative).
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Vancomycin in TKAs
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Concentration of vancomycin in bone, synovial tissue, subcutaneous fat and serum bloodIntraoperative